Abstract
The paper provides information on the safety and diagnostic efficacy of macrocyclic magnetic resonance contrast agents, such as gadobutrol, gadoteridol, and gadoteric acid. It is concluded that the standard gadobutrol dose of 0.1 mmol/kg body weight has a favorable safety profile and is well tolerated by children, including by newborn infants and adults. Owing to the increased relaxivity and double concentration of gadolinium, gadobutrol, as compared to gadoteridol and gadoteric acid, has a higher diagnostic efficacy and pharmacoeconomic advantages.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
